Back to search

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of Cardiology

Data up to Jan 2025

Published2000
Citations491
References84

Total Citations Per Year

Abstract

References (84)

Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency

1999 • 1,959 citations

MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia

1999 • 1,344 citations

Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

1999 • 1,013 citations

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

1993 • 843 citations

Low Penetrance in the Long-QT Syndrome

1999 • 817 citations

Electrophysiological remodeling in hypertrophy and heart failure

1999 • 743 citations

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

1992 • 698 citations

Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.

1989 • 675 citations

Terfenadine-Ketoconazole Interaction

1993 • 654 citations

The Use ofXenopusOocytes for the Study of Ion Channel

1987 • 649 citations

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

1990 • 607 citations

The M Cell:

1999 • 606 citations

Characteristics of the Delayed Rectifier Current (IKrand IKs) in Canine Ventricular Epicardial, Midmyocardial, and Endocardial Myocytes

1995 • 605 citations

Quinidine Syncope

1964 • 570 citations

Cellular Basis for the ECG Features of the LQT1 Form of the Long-QT Syndrome

1998 • 499 citations

Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care

1986 • 489 citations

Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation

1996 • 484 citations

Clinical relevance of cardiac arrhythmias generated by afterdepolarizations

1994 • 483 citations

Measurement of the QT interval and the risk associated with QTc interval prolongation: A review

1993 • 479 citations

Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patients

1983 • 466 citations

Food and Drug Administration

2011 • 459 citations

Characteristics and Distribution of M Cells in Arterially Perfused Canine Left Ventricular Wedge Preparations

1998 • 449 citations

Sex Difference in Risk of Torsade de Pointes With d,l- Sotalol

1996 • 447 citations

Extracellular Potassium Modulation of Drug Block of I Kr

1996 • 437 citations

The Electrophysiological Mechanism of Ventricular Arrhythmias in the Long QT Syndrome

1996 • 425 citations

Sex Hormones Prolong the QT Interval and Downregulate Potassium Channel Expression in the Rabbit Heart

1996 • 368 citations

[16] Electrophysiologic recordings from Xenopus oocytes

1998 • 361 citations

Correction of the QT interval for heart rate: Review of different formulas and the use of Bazett's formula in myocardial infarction

1985 • 315 citations

HERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine

1996 • 294 citations

Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations?

1989 • 276 citations

Regional Differences in Electrophysiological Properties of Epicardium, Midmyocardium, and Endocardium

1996 • 254 citations

Enhanced Susceptibility for Acquired Torsade de Pointes Arrhythmias in the Dog With Chronic, Complete AV Block Is Related to Cardiac Hypertrophy and Electrical Remodeling

1998 • 243 citations

QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the Rabbit

1990 • 238 citations

Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride

1997 • 225 citations

The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization

2000 • 223 citations

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

1993 • 218 citations

Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts

1994 • 213 citations

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine

1995 • 212 citations

Gender difference in the cycle length-dependent QT and potassium currents in rabbits.

1998 • 208 citations

Torsade de pointes due to quinidine: Observations in 31 patients

1984 • 205 citations

Reproducible Induction of Early Afterdepolarizations and Torsade de Pointes Arrhythmias by d -Sotalol and Pacing in Dogs With Chronic Atrioventricular Block

1995 • 192 citations

Pause induced early afterdepolarizations in the long QT syndrome: a simulation study

1999 • 191 citations

Committee for Proprietary Medicinal Products (CPMP)

2009 • 178 citations

Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?

1997 • 157 citations

Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods

1996 • 154 citations

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability

1996 • 143 citations

Proarrhythmia With Class III Antiarrhythmic Drugs: Types, Risks, and Management

1997 • 143 citations

Inherited Long QT Syndromes:

1999 • 140 citations

Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells.

1992 • 138 citations

Polymorphous ventricular tachycardia associated with normal and long Q-T intervals

1982 • 133 citations

IK of rabbit ventricle is composed of two currents: evidence for IKs

1996 • 131 citations

Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in Patients with Chronic Atrial Fibrillation or Flutter: A Prospective Study

1998 • 122 citations

Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium

1997 • 121 citations

Acceleration‐Induced Action Potential Prolongation and Early Afterdepolarizations

1998 • 117 citations

Use of Terfenadine and Contraindicated Drugs

1996 • 107 citations

The Novel Class III Antiarrhythmics NE-10064 and NE-10133 Inhibit Isk Channels Expressed in Xenopus Oocytes and Iks in Guinea Pig Cardiac Myocytes

1994 • 94 citations

Electrophysiologic Features of Torsades de Pointes:

1997 • 92 citations

Cisapride‐Induced Torsades de Pointes

1998 • 86 citations

Academic medical center.

1985 • 85 citations

Efficacy and Safety of d,l-Sotalol in Patients With Ventricular Tachycardia and in Survivors of Cardiac Arrest

1997 • 80 citations

“Optimum” Formulae for Heart Rate Correction of the QT Interval

1999 • 74 citations

Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes

1995 • 66 citations

Drug-Related Torsades de Pointes in the Isolated Rabbit Heart

1998 • 63 citations

Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.

1991 • 62 citations

Variability of Recovery of Excitability in the Normal Canine and the Ischaemic Porcine Heart

1985 • 56 citations

Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol

1999 • 53 citations

Effects of Epinephrine and Phenylephrine on QT Interval Dispersion in Congenital Long QT Syndrome 11This study was supported by a grant from the Finnish Cardiac Research Foundation, Helsinki.

1998 • 52 citations

Torsade de pointes ventricular tachycardia a complication of disopyramide shared with quinidine

1981 • 51 citations

Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome

1996 • 49 citations

Terfenadine Increases the QT Interval in Isolated Guinea Pig Heart

1995 • 47 citations

Exploring the Hidden Danger of Noncardiac Drugs

1998 • 40 citations

Clofilium in the isolated perfused rabbit heart: A new model to study proarrhythmia induced by class III antiarrhythmic drugs

1998 • 36 citations

Differential electrophysiology of repolarisation from clone to clinic

1997 • 23 citations

Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in patients With Chronic Atrial Fibrillatio and Flutter

1998 • 16 citations

Unwitting Exposure to Risk

1993 • 15 citations

Use of terfenadine and contraindicated drugs

1996 • 14 citations

Of Oocytes and Runny Noses

1996 • 13 citations

Informed Consent for Genetic Research-Reply

1996 • 13 citations

Chapter 8: Blood Volume

1985 • 10 citations

Electrophysiological effects of LU111995 on canine hearts: in vivo and in vitro studies.

1999 • 9 citations

[Paradoxic response to disopyramide and quinidine (author's transl)].

1980 • 9 citations

Pharmacokinetic and Pharmacodynamic Drug Interactions with Antiarrhythmic Agents

1997 • 8 citations

[Torsade de pointes ventricular tachycardia].

1984 • 3 citations

Electrophysiological Recordings

2000 • 2 citations

Cited By (0)

Loading...
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs:… (2000) – Cardiovascular Research | Metascience Observatory Explorer